Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Hazardous Material Transportation via U.S.-Flag Vessels

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the ocean transportation of hazardous materials via U.S.-flag vessels, requiring strict adherence to DFARS 252.247-7023 and MARAD regulations. This includes full compliance with documentation standards, logistics coordination, and all safety and security protocols mandated for handling dangerous goods during maritime transit. The work is being procured as a subcontract under the Department of Defense’s Medical Supply Chain PHARM FSA, with performance expected to originate from Morrisville, North Carolina, 27560. The solicitation, posted on July 23, 2026, requires proposals to be submitted by July 29, 2026, and falls under the NAICS code 488390 for other support activities for water transportation. All parties must ensure operational alignment with federal defense supply chain protocols and maintain the integrity of the U.S.-flag vessel requirement throughout the transport lifecycle.

General Info

U.S.-flag ocean transport of hazardous materials under DoD supply chain, complying with DFARS and MARAD, from Morrisville, NC.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

488390 - Other Support Activities for Water TransportationView NAICS

Place of Performance

MORRISVILLE, NC, 27560-0000, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Ocean transport of hazardous materials using U.S.-flag vessels in compliance with DFARS 252.247-7023 and MARAD requirements, including documentation and logistics coordination.

Similar Contracts

Same NAICS industry code

NAICS: 488390
New
DIBBS
Domestic and International Shipping Compliance (U.S.-Flag Vessel Certification)The contract requires comprehensive documentation and certification to ensure compliance with U.S. ocean transport regulations, specifically focusing on the use of U.S.-flag vessels or the acquisition of a MARAD waiver when such use is not feasible. Successful bidders must demonstrate full adherence to applicable maritime laws and provide verifiable evidence of vessel flag status or approved waivers, ensuring legal and regulatory alignment for both domestic and international shipping operations under the Department of Defense’s oversight. The performance location is designated as JB MDL with a zip code of 08641-5500, and the work falls under NAICS code 488390 for other support activities for water transportation. This is a subcontract opportunity posted by the ASC Commodities Division of the Department of Defense, with a response deadline of July 31, 2026. The solicitation is open for submission through the DIBBS platform, and all applicants must be prepared to meet stringent compliance standards related to maritime transport. There is no specified set-aside type, meaning the contract is open to all qualified entities regardless of business size or status, and the primary objective is to secure reliable, auditable proof of compliance to facilitate lawful cargo movement under U.S. flag or authorized exceptions.
ASC COMMODITIES DIVISION

POSTED

4 days ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection, USP 0.9% 1000mL IV Plastic Bag, Latex Free, is being procured under solicitation SPE2DP-26-T-4286 with a delivery requirement of 20 days after award to the destination in East Greenwich, Rhode Island, with FOB Destination terms placing full transportation responsibility and risk on the contractor until delivery. The item is identified by NSN 6505013306269 and is offered in units of 12 per package (PG), with a base quantity of 3 PG and a historical procurement range extending up to 33 PG, all at a unit price of $33.41. The product must meet USP standards and be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat, and stored away from incompatible materials. The item has a non-extendable shelf life of 30 months as a TYPE I (CODE P) item and is regulated by the FDA. Packaging and marking must adhere strictly to Medical Marking Standard No. 1 (MMS NO. 1), superseding MIL-STD-129, and preservation and packing must comply with MIL-STD-2073-1E. All units must be sealed in commercial containers designed to prevent damage during transit, with export packaging employed when necessary, and shipped via common carrier at the lowest feasible rate. Hazardous material labeling is required per OSHA 29 CFR 1910.1200 and DFARS 252.223-7001, with Safety Data Sheets mandated prior to award and updates required if chemical composition changes. The contract includes compliance with multiple FAR and DFARS clauses related to equal opportunity, combating trafficking, employment eligibility verification, sustainable products, cybersecurity safeguards, and unenforceability of unauthorized obligations. Offerors must provide a Unique Entity ID and disclose size status and socioeconomic designations including small business, WOSB, SDVOSB, HUBZone, or SDB. Payment must be processed through Wide Area WorkFlow (WAWF) using appropriate document types, and all proposals must be submitted electronically via DIBBS by the deadline of August 3, 2026. The contract is administered by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection 0.9% in 250 mL units, packaged 24 bags per purchase group, is being procured under solicitation SPE2DP-26-T-4271 with a delivery requirement of five days FOB destination. The item is regulated by the FDA and must comply with strict packaging and marking standards as defined by Medical Marking Standard No. 1, superseding all references to MIL-STD-129. Each unit must be sealed in commercial-grade containers that protect against damage and breakage, and all exterior shipping containers must ensure safe, cost-effective delivery by common carriers. The product has a non-extendable shelf life of 24 months and must be stored at room temperature with brief exposure to up to 40°C permitted without adverse effect. The item is identified by NSN 6505-01-331-8945 and is subject to zero variance in quantity, with inspection and acceptance occurring at the destination. Multiple manufacturers including B. Braun Medical Inc., ICU Medical Inc., Trillamed LLC, and Cardinal Health 200, LLC are qualified suppliers, each identified by specific NDC numbers and part numbers. All packaging and labeling must conform to the latest Medical Marking Standard No. 1, available through DLA Troop Support, and the solicitation includes requirements for covered defense information. The contracting officer must submit a referral in EBS for product confirmation prior to award, including bidder and manufacturer details.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
ACEPROMAZINE MALEATE IACEPROMAZINE MALEATE INJECTION, VETERINARY, 10MG/ML in 50ML vials, is being procured under solicitation SPE2DP-26-T-4274 for use in cats, dogs, and horses, with explicit prohibition against use in horses intended for human consumption. The unit of issue is a vial (VI), and the contract calls for delivery of two vials, with a firm fixed price of $25.03 per vial, resulting in a total estimated contract value of approximately $1,078. Delivery is required within 62 days after award, FOB destination, to a designated military medical logistics center in Kaiserslautern, Germany. The product must be stored at controlled room temperature, between 20–25°C (68–77°F), and carries a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. Packaging must strictly adhere to MIL-STD-2073-1E, and all marking must comply with the latest Medical Marking Standard No. 1, superseding MIL-STD-129. As a hazardous material, the product requires GHS-compliant labeling under OSHA’s Hazard Communication Standard (29 CFR 1910.1200), with Safety Data Sheets submitted and approved prior to award. The supplier must also train personnel on SDS and labeling requirements and ensure all packaging and labeling meet the updated Federal Standard No. 313-E. Transportation of the shipment by sea must be conducted using U.S.-flag vessels unless a waiver is granted with prior documentation. The contract includes mandatory compliance with numerous DFARS clauses, including those addressing disclosure of information, whistleblower rights, restrictions on former DoD officials’ compensation, control of government work product, and NIST SP 800-171 cybersecurity requirements. The contractor must provide a Unique Entity Identifier and CAGE code, represent its small business status if applicable, and certify compliance with socioeconomic program requirements. Inspection and acceptance occur at destination, with full responsibility for quality, packaging, and regulatory compliance resting with the supplier. All proposals must be submitted electronically via the DLA Internet Bid Board System by the August 3, 2026 deadline, following DLA’s Master Solicitation for Automated Simplified Acquisitions.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE TOPICAPOVIDONE-IODINE TOPICAL SOLUTION, USP, is a regulated pharmaceutical product procured under contract SPE2DP-26-T-4280 for U.S. military use, with each unit being a 4 fluid ounce (118 mL) bottle identified by the unit of issue BT and NSN 6505010672812. The product must comply with stringent technical and quality requirements from the DLA Master List, including a mandatory 36-month shelf life, of which at least 31 months must remain at time of delivery to the first government activity. Labeling must conform to MED.MARKING STD 1A, specifying key elements such as manufacturer and CAGE code, manufacturing and expiration dates, contract and lot numbers, and the unit designation 1 BT = 4 OZ. The product is subject to FDA regulation and requires pre-award referral through EBS for validation. Packaging must be commercial-grade, sealed to prevent damage, and shipped in exterior containers ensuring safe transit at minimal cost, adhering to DLA’s packaging directives over ASTM D3951 when applicable, with all marking strictly following MIL-STD-129 despite references to MMS No. 1. The material is classified as non-hazardous per FED-STD-313 and must be shipped by traceable means only, prohibiting parcel post. Two delivery points are specified: Fort Bragg, NC and Fort Bliss, TX, each requiring shipment within 20 days of contract award with no tolerance for quantity variance. Delivery is FOB destination, with inspection and acceptance occurring at the final location. The solicitation lists Cardinal Health 200, LLC and Purdue Pharma LP as potential manufacturers under NDC 67618-0150-04, and procurement is coordinated through DLA Troop Support, with point of contact Shairy M. Cartagena.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 424210
New
DIBBS
DANTROLENE SODIUM FORDantrolene Sodium for Injection, USP, 250mg per vial, is procured under contract SPE2DP-26-T-4289 with a total quantity of six vials, each containing 20 mL. The item is regulated by the FDA and requires strict adherence to packaging, labeling, and storage specifications. Each vial must be sealed in a protective unit container and packed in commercial shipping containers suitable for safe transport by common carriers at the lowest rate, with delivery required FOB destination within five days. Packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must include the NSN, manufacturer and CAGE code, contract number, lot number, date of manufacture, and expiration date. The unopened product must be stored at controlled room temperature between 20 to 25 degrees Celsius and protected from light. The item has a non-extendable shelf life of 24 months, designated as a TYPE I (CODE M) item under RS001. Only approved manufacturers—Cardinal Health, AmerisourceBergen, and Eagle Pharmaceuticals—are listed with matching NDC codes. All packaging must conform to the DLA Master List of Technical and Quality Requirements, which take precedence over commercial standards like ASTM D3951. The material is not considered hazardous under FED-STD-313 and must be shipped via the fastest traceable means, excluding parcel post, to the designated delivery point at Fort Bragg, North Carolina. The required delivery date is July 27, 2026, and the solicitation response deadline is August 3, 2026.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTZinc Oxide Ointment USP, containing 20% zinc oxide in a 28.35 gram collapsible tube, is a topical skin protectant procured under solicitation SPE2DP-26-T-4279 with a requirement for five units of issue. The product must comply with the latest Medical Marking Standard No. 1, be labeled with NDC 67777-0223-11, and be manufactured by Dynarex Corp under part number 1TVZ3. It is subject to a non-extendable shelf life of 36 months as a TYPE I Q-coded item and must be stored at controlled room temperature not exceeding 30°C. Packaging must adhere to DLA Packaging Requirements for Procurement, MIL-STD-129, and ASTM D3951 if non-hazardous, with all markings and labeling controlled by the DLA Master List of Technical and Quality Requirements. The item is regulated by the FDA, requiring referral through EBS for confirmation, and is subject to Covered Defense Information protocols. Delivery is FOB destination within 20 days of contract award, with no variance allowed in quantity, inspection and acceptance occurring at the destination point. The sole delivery address is W51JYU, 0165 CS HHC HHC Combat Sustainment, Bossier City, LA 71111-5397, and shipment must be sent via traceable means, excluding parcel post. The contract specifies a unit price of $5.00 per tube, totaling $25.00, with the original required delivery date set for July 28, 2026. All technical and quality obligations referenced by R-numbers are governed by the DLA Master List in effect on the solicitation issue date, and the product must be palletized in accordance with RP001. Government use only identifiers and tracking codes, including the TCN and SUPP ADD, are included for logistics and accountability purposes, with the contracting office listed as the Department of Defense, Medical Supply Chain PHARM FSA.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
VECURONIUM BROMIDE FORVecuronium Bromide for Injection is a freeze-dried powder containing 10 mg of the active ingredient, supplied in packages of ten vials per unit, with a total shelf life of 24 months. At the time of receipt by the first government activity, the product must have a minimum of 21 months of remaining shelf life, and storage must be maintained at controlled room temperature between 20 to 25°C (68 to 77°F), protected from light and retained in its original carton until use. The item is classified as a Type I (Code M) medical supply with a non-extendable shelf life, and all packaging and marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a protective container and packed in commercial shipping containers ensuring safe delivery at the lowest cost to the specified destination, with strict adherence to hazardous materials shipping protocols. The product, manufactured by Hikma Pharmaceuticals USA Inc., is identified by NDC 00143-9234-10 and NSN 6505-01-258-0983, and is required for delivery to JBER, Alaska, under contract SPE2DP-26-T-4283 with a firm delivery date of July 28, 2026. The procurement specifies a fixed quantity of three units totaling two packages, with no variance permitted, and all shipments must be routed through designated government freight and parcel post addresses. Compliance with DLA packaging, technical, and quality requirements, as outlined in the DLA Master List and supporting directives, is mandatory.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOLBenzocaine and Menthol Lozenge, marketed as CEPACOL EXTRA STRENGTH SORE THROAT HONEY LEMON LOZENGES, contains 15 mg of benzocaine and 2.6 mg of menthol per lozenge as an oral pain reliever, packaged in units of 16 lozenges and requiring storage at 20–25 °C (68–77 °F) with protection from humidity. The product is procured under solicitation SPE2DP-26-T-4285 by the Department of Defense through DLA Troop Support, with supply chain compliance governed by Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a protective container, and shipments must be packed in commercial exterior containers designed for safe, low-cost transport to the delivery point. The item has a non-extendable shelf life of 36 months (TYPE I, CODE Q) and is subject to strict packaging and marking protocols per DLA packaging requirements, including palletization standards and commercial packaging specifications. The NSN 6505017081449 applies to both contract lines, with total quantities of 6 and 25 packages respectively, both subject to zero variance in delivery quantity. Delivery is FOB destination within five days of requirement, with no parcel post permitted; shipments must use traceable freight methods to specified military locations at Fort Bragg, North Carolina. The products are sourced from Reckitt Benckiser LLC and RB Health US LLC under NDC 638240732-16, and all items must meet technical and quality standards referenced in the DLA Master List of Technical and Quality Requirements. The contract designates destination as both inspection and acceptance point, with no tolerance for deviation from quantity or packaging specifications. Government use codes and logistics identifiers are embedded for internal tracking, and the original required delivery dates are July 28 and 29, 2026, respectively. The solicitation response deadline is August 3, 2026, and the procurement is classified under NAICS code 325411 for pharmaceutical preparation manufacturing.
Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 424210
New
DIBBS
LIDOCAINE GELLidocaine 4% Gel with Aloe Vera is a topical pain relief product intended for use on sunburn, scrapes, and insect bites, formulated to be fragrance-free and packaged in 4OZ (118ML) containers. Each unit must be sealed in a protective container that prevents damage or breakage, and all units must be packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the designated point of delivery. The product has a mandatory 24-month shelf life, with no more than three months allowed to have passed from the date of manufacture to the date of government delivery, and it is classified as a Type 01 shelf life item. Storage must not exceed 100 degrees Fahrenheit. Packaging and marking must strictly comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129, and details for this standard are available through DLA Troop Support. The product is identified by NSN 6505-01-695-6400 and part number 814660011517, with 12 containers per box as the unit of issue. Delivery is required within five days of contract award, FOB destination, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. Shipments must be sent via the fastest traceable means, excluding parcel post, to the designated military facility at Fort Bragg, North Carolina. The solicitation number is SPE2DP-26-T-4273, with a required delivery date of July 27, 2026, and the supplier is United Spirit of America Inc.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100mg in bottles of nine tablets, are being procured under solicitation SPE2DP-26-T-4284 by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA for delivery to Joint Base Elmendorf-Richardson in Alaska. The item is regulated by the FDA and must be stored at 20 to 25°C (68 to 77°F), protected from light, with a non-extendable shelf life of 24 months as a Type I (Code M) item. The contract specifies delivery within five days of order, FOB destination, with inspection and acceptance occurring at the delivery point. Packaging must adhere to MIL-STD-2073-1E and be palletized per DLA’s RP001 requirements, with labeling and marking fully compliant with MIL-STD-129 and the latest Medical Marking Standard No. 1, including mandatory 2D Data Matrix barcodes. The unit of issue is a bottle, and the sole line item quantity is one bottle, with an estimated value of $18.77 based on prior procurement history. The NSN is 6505-01-727-8704, and the manufacturers listed are Mylan Pharmaceuticals Inc. and Golden State Medical Supply, Inc., with respective NDC codes. All supplies must be free of government identification upon rejection and comply with covered defense information requirements under RD003 and safeguards for cyber incident reporting under 252.204-7012. Invoicing must be submitted through Wide Area WorkFlow, and contractors must adhere to all applicable FAR clauses including 52.213-4 for simplified acquisitions, 52.216-1 with Alternate I for contract type, and provisions on hazardous materials, trafficking in persons, employment eligibility, and sustainable products. Offerors must complete required representations in Section K regarding small business status, UEI and CAGE codes, and compliance with prohibitions on covered telecommunications equipment, though no completed responses are provided in the solicitation. Proposals must be submitted electronically via DIBBS by August 3, 2026, using SF-18, with no page limits specified. The contract includes no option quantities, and the place of performance is fixed at the specified JBER address.
Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is subject to strict packaging and marking requirements mandated by the Department of Defense. Each unit must be sealed in a protective container to prevent damage or breakage, and all shipments must be packed in commercial exterior containers suitable for safe transport via common carrier at the lowest cost to the designated delivery point. Packaging must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all markings must adhere to the latest edition of this standard as published by DLA Troop Support. The product is regulated by the FDA and requires confirmation by a product specialist prior to award, with bidder and manufacturer details submitted through EBS. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure to up to 40°C permitted without adverse effects. It is prohibited from freezing and must be protected from excessive heat. The contract specifies a quantity of 2 packaging groups, each containing 12 units, for delivery to Dyess AFB within 20 days under FOB destination terms with zero variance allowed. Inspection and acceptance occur at the delivery point, and the item is identified by NSN 6505-01-330-6267 and manufacturer part number NDC00264-7750-00 under B. BRAUN MEDICAL INC. The solicitation, issued under contract SPE2DP-26-T-4292, has an August 3, 2026 response deadline and falls under NAICS code 325412 for pharmaceutical manufacturing.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 7 days
View Details